Atrial fibrillation and in-hospital mortality in Covid-19 patients

Back

EHRA Premium Access

Atrial fibrillation and in-hospital mortality in Covid-19 patients

Session: Atrial Fibrillation - Round 1 - Drugs, Prevention

Topic: Prevalence and Incidence of Atrial Fibrillation

Speaker: Doctor I. Kotadia (London, GB)

Event: EHRA 2023

Congress Presentation

Add to my library

About the speaker

Doctor Irum Kotadia

King's College London, London (United Kingdom of Great Britain & Northern Ireland)

0 follower

5 more presentations in this session

Atrial fibrillation screening to prevent stroke in patients with high NT-proBNP - a post-hoc analysis of the randomized LOOP study

Speaker: Doctor S. Diederichsen (Copenhagen, DK)

Atrial fibrillation is an independent risk factor for heart failure progression and pump failure mortality in HFpEF:: a propensity score matched analysis of the TOPCAT Americas study

Speaker: Professor D. Shah (Geneva, CH)

Effects of antiarrhythmics on atrial high rate episodes and progression to clinical atrial fibrillation (ANTI-AHRE)

Speaker: Doctor S. Simovic (Kragujevac, RS)

Improved prognosis with integrated care management including early rhythm control and healthy lifestyle modification in patients with concurrent atrial fibrillation and diabetes mellitus

Speaker: Doctor H. Ahn (Seoul, KR)

Active monitoring for atrial fibrillation (AMALFI): a streamlined randomised controlled trial of remote screening for subclinical atrial fibrillation

Speaker: Doctor R. Wijesurendra (Oxford, GB)

Access the full session

Atrial Fibrillation - Round 1 - Drugs, Prevention

Speakers: Doctor I. Kotadia, Doctor S. Diederichsen, Professor D. Shah, Doctor S. Simovic, Doctor H. Ahn...

Access

Video

About the event

EHRA 2023

16 April - 18 April 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources